European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 121-124 , February 2010

Implementation of guidelines on oxytocin use at caesarean section: A survey of practice in Great Britain and Ireland

  • Sharon R. Sheehan

      Affiliations

    • Academic Department of Obstetrics & Gynaecology, Coombe Women and Infants University Hospital & Trinity College, University of Dublin, Dublin 8, Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 1 4085200; fax: +353 1 4536033.
    • ,
  • Lilantha Wedisinghe

      Affiliations

    • Department of Obstetrics & Gynaecology, Ninewells Hospital & Medical School, University of Dundee, Dundee, Scotland, United Kingdom
    • ,
  • Maureen Macleod

      Affiliations

    • Division of Maternal and Child Health Sciences, Ninewells Hospital & Medical School, University of Dundee, Dundee, Scotland, United Kingdom
    • ,
  • Deirdre J. Murphy

      Affiliations

    • Academic Department of Obstetrics & Gynaecology, Coombe Women and Infants University Hospital & Trinity College, University of Dublin, Dublin 8, Ireland

Received 22 May 2009 ,Revised 17 August 2009 ,Accepted 2 October 2009.

References 

  1. Martin JA, Hamilton BE, Ventura SJ, Mnacker F, Park MM, Sutton PD. Births: final data for 2001. Hyattsville: National Centre for Health Statistics, Division of Vital Statistics; 2002;p. 1
  2. Thomas J, Paranjothy S, Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. National Sentinel Caesarean Section Audit Report. 2RCOG Press; 2001.
  3. Cai WW, Marks JS, Chen CH, Zhuang YX, Morris L, Harris JR. Increased caesarean section rates and emerging patterns of health insurance in Shanghai, China. Am J Pub Health. 1998;88:777–780
  4. Births in Scotland report (Births 1981–2000) Information and Statistics Division; 2002. www.show.scot.nhs.uk/isd/sexual_health.
  5. Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour (Cochrane Review). vol. 1. Chichester, UK: John Wiley & Sons, Ltd.; 2004;[the Cochrane Library]
  6. Bolton TJ, Randall K, Yentis SM. Effect of the confidential enquiries into maternal deaths on the syntocinon at caesarean section in the UK. Anaesthesia. 2003;58:277–279
  7. Khan MM, Gupta S, Radford P, Male DA. Dose of oxytocin after caesarean section. Anaesthesia. 2002;57:723–724
  8. Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section—a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol. 2008;137:27–30
  9. Caesarean Section . Clinical guideline. National Collaborating Centre for Women's and Children's Health. London: RCOG Press; 2004;
  10. Anderson J, Etches D, Smith D. Postpartum haemorrhage. In:  Damos JR,  Eisinger SH editor. Advanced life support in obstetrics (ALSO) provider course manual. Kansas: American Academy of Family Physicians; 2000;pp. J1–15
  11. Murphy DJ, MacGregor H, Munishankar B, McLeod G. A randomised controlled trial of oxytocin 5IU and placebo infusion versus oxytocin 5IU and 30IU infusion for the control of blood loss at elective caesarean section—Pilot study. ISRCTN40302163. Eur J Obstet Gynecol Reprod Biol. 2009;142:30–33
  12. Bolton TJ, Randall K, Yentis SM. Effect of the confidential enquiries into maternal deaths on the use of syntocinon at caesarean section in the UK. Anaesthesia. 2003;58:277–279
  13. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005–1010
  14. Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol. 2006;107:45–50
  15. Lombaard H, Pattinson RC. Common errors and remedies in managing postpartum haemorrhage. Best Prac Res Clin Obstet Gynaecol. 2009;23:317–326
  16. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277:312–317
  17. Murphy JF. The Lourdes Hospital inquiry: its implications for medical practice. Ir Med J. 2006;99(March (3)):68–69
  18. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113:919–924
  19. Murphy DJ, Carey M, Montgomery AA, Sheehan SR ECSSIT Study Group. Study Protocol. ECSSIT—Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5IU bolus and placebo infusion versus oxytocin 5IU bolus and 40IU infusion for the control of blood loss at elective caesarean section. BMC Pregnancy Childbirth. 2009;9:36

PII: S0301-2115(09)00596-X

doi: 10.1016/j.ejogrb.2009.10.004

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 121-124 , February 2010

Article Tools